Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bepridil | 2351 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | bepridil | 2351 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | bepridil | 2351 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | bepridil | 2351 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | bepridil | 2351 | drug-path |
| Asthma | R-HSA-444620 | map05310 | bepridil | 2351 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | bepridil | 2351 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | bepridil | 2351 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | bezafibrate | 39042 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | bezafibrate | 39042 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dequalinium chloride | 38945 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | dequalinium chloride | 38945 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | dequalinium chloride | 38945 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | dequalinium chloride | 38945 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | dequalinium chloride | 38945 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | dequalinium chloride | 38945 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | dequalinium chloride | 38945 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | xamoterol | 155774 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | xamoterol | 155774 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | xamoterol | 155774 | drug-path |